Live Breaking News & Updates on Weight loss drugs

Stay informed with the latest breaking news from Weight loss drugs on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Weight loss drugs and stay connected to the pulse of your community

Weight-loss drugs: Who, and what, are they good for?

The new drugs are known as GLP-1 agonists, which mimic the activity of a hormone that slows digestion and helps people feel full for longer. In clinical trials, people lost 15% to 20% of their body weight, depending on the drug. Nearly 120 million American adults could be eligible for treatment, while Novo says its target market is more than 760 million people with obesity worldwide.

United-states , Michigan , American , Susan-yanovski , Andres-acosta , Lauren-eberly , Novo-nordisk-wegovy , Eli-lilly , Lauren-oshman , University-of-michigan-department-family-medicine , Novo-nordisk , Astrazeneca-plc

diabetes drug: What other health conditions might weight-loss drugs treat?

New data suggests that semaglutide may also cut the risk of stroke or heart attack, and may delay the progression of kidney disease in diabetes patients.

Denmark , University-hospital , Ohio , United-states , Cincinnati , France , Danish , Los-angeles , Eli-lilly , Chinese-university-of-hong-kong , Danish-headache-center , Novo-nordisk

Bears Target Heavily Shorted WW International Stock

Options bears are blasting WW International (WW) today, with 2,010 puts exchanged so far – double the intraday average volume.

Cboe-options-exchange , Ww-international , International-securities-exchange , Novo-nordik , Ww-international-stock , Ww-stock , Weight-watchers , Ww-puts , Ww-calls , Ww-stock-options , Ozempic-news

Obesity Drug Set to Exceed Ozempic With $27B Sales by 2029

Mounjaro, a weight loss medication, is projected to outpace Ozempic, driven by convincing clinical results and anticipated sales of $27 billion by 2029.

United-kingdom , Canada , Astrazeneca-forxiga , Kevin-marcaida , Eli-lilly-mounjaro , Eli-lilly , Novo-nordisk-wegovy , Novo-nordisk-ozempic , Regulatory-agency , Novo-nordisk , Superiority-over-ozempic , Weight-loss

indiamart illegal wegovy sales: Indiamart working with Novo Nordisk to halt illegal Wegovy sales

The drugmaker's India legal team held discussions with Indiamart's top executives to develop a "framework" for regularly alerting the online marketplace about listings by counterfeiters in an effort to curtail illegal sales, the source said on condition of anonymity.

Denmark , Bangladesh , Lucknow , Uttar-pradesh , India , Hyderabad , Andhra-pradesh , Danish , Vikrant-shrotriya , Eli-lilly-mounjaro , Indian-pharma-network , Technology-leadership

nestle: Weight loss drugs not a threat to Nestle biz: CEO Mark Schneider

Nestle CEO Mark Schneider has defended its strategy of building a lower-calorie product portfolio, stating that the threat of GLP-1 weight-loss drugs is less significant. The company now generates half of its revenue from coffee, pet care, and vitamins, a shift from 30% seven years ago. Schneider expects the vitamins, minerals, and supplements business to grow in the mid- to high-single digits.

Mark-schneider , Nestle , Lean-cuisine , Schneider , Weight-loss-drugs , Weight-loss , Nestle-sa ,

Oprah Winfrey Admits She DID Use Weight-Loss Drugs For Dramatic 40-pound Transformation After Previously DENYING She'd Ever Take Ozempic: 'I'm Done With Embarrassment' » WhatsNew2Day

Oprah Winfrey has finally admitted that she used weight-loss drugs for her dramatic body transformation, after previously denying that she would ever take

New-york , United-states , Colorado , Sima-sistani , Oprah-winfrey , Winfrey-admits-she , Weight-loss-drugs , Oprah-winfrey-admits-she , Transformation-after-previously , Ever-take-ozempic , Im-done-with-embarrassment-

Reversing Weight Loss: Breakthrough in Halting Eli Lilly's Zepbound Effects

Weight loss drugs like Wegovy and Ozempic have also caused weight regain, sparking concerns among health insurers over the costly long-term coverage of these drugs.

Weight-loss-drugs , Eight-gain , Epbound ,

Discontinuing Zepbound Leads To Weight Rebound: This Matters To Payers

The implication of the weight rebound effect upon discontinuing Zepbound is that insurers must reimburse indefinitely for those who wish to continue on the drug.

United-states , American , Journal-of-the-american-medical-association , American-medical , Glp-1 , Tirzepatide , Zepbound , Weight-loss-drugs , Gip-glp-1 , Dropout-rate , Insurers

To keep pounds off, patients may need to continue taking weight loss drug, study

People who take the new injectable medication tirzepatide – brand-named Zepbound – to shed pounds will need to stay on it if they want to keep the weight off, a new study confirms.

United-states , New-york , Americans , Louis-aronne , Melanie-jay , Eli-lilly , Langone-comprehensive-program-on-obesity , Weill-cornell-medicine , Comprehensive-program , Abc-action-news , National-news , Wfts